Our quality policy
This statement of purpose constitutes the quality policy for Viapath Group and is applicable to both Viapath Analytics and Viapath Services.
Viapath is an independent pathology provider registered with the Care Quality Commission.
Viapath Group is a Limited Liability Partnership registered in England & Wales under number OC337242. The registered address is Francis House, 9 King’s Head Yard, London, SE1 1NA.
Viapath consists of three legal entities:
- Viapath Group (corporate functions)
- Viapath Services (support services e.g. HR, IT)
- Viapath Analytics (laboratory services)
The Care Quality Commission
The Care Quality commission is the independent regulator of all health and social care services in England.
Viapath is an independent pathology provider registered with the Care Quality Commission to provide:
- Diagnostic and screening services
- Blood and Transplant services
The locations of the services and the CQC Registrant Managers are listed below:
Great Maze Pond
London SE1 9RT
St Thomas Hospital
Westminster Bridge Road
London SE1 7EH
Ms Analie Booth – Director of Operations – Reference services
Kings College Hospital
Denmark Hill SE5 9RS
Princess Royal University Hospital
Orpington, BR6 8ND
Miss Elizabeth Ford – Director of operations – Core services
Bedford, MK42 9DJ
Mr Guy Humphrey – General Manager
The current accreditation status of our laboratories can be viewed on the UKAS website which can be accessed via the link below:
Laboratories not currently accredited are working towards achieving accreditation to ISO 15189:2012.
Viapath is a clinically led, customer focused and scientifically driven full service pathology provider of accurate, timely and clinically useful prognostic, diagnostic and screening results, blood and blood products, with clinical advice provided by NHS Consultants, to the NHS and private sector locally, nationally and internationally. Services include core pathology such as Blood Sciences, Tissue Sciences and Infection Sciences, typically delivered from each operational site and specialised tests such as Genetics, Clinical Transplantation and Biochemical Sciences delivered from centres of excellence. These Services participate in research, development and clinical trials. A detailed scope for each location is available.
Viapath has established continuous quality improvement as a business philosophy for all processes and services to support safe and effective patient care. Viapath continually monitors its activity, annually reviews this policy for its suitability and effectiveness.
Viapath publishes an annual Quality Account which reviews the previous year governance, risk and quality process and improvements, with a particular focus on openness and learning when things do not go according to plan. It is a statutory requirement to publish the account, because we deliver services to NHS funded patients. It is published on NHS Choices and can also be accessed via the Viapath website.
Services complete an Annual Management Review to ensure objectives are monitored locally and changes or new systems, processes or procedures are implemented effectively. Satisfaction of users is seen as a key indicator of success in improvement of services. Viapath is proactive in managing its business risks and has plans in place to ensure service continuity in all events.
Viapath strives to maintain and develop a high quality, flexible workforce that is committed, engaged, trained and supported to provide the highest level of service to our users in accordance with relevant good professional guidance. Through recruitment, induction and training, employees will be made familiar with this policy and relevant content and procedures of the management system. Viapath’s commitment to quality commences at the point of initial contact with potential employees through a Quality statement in every job description.
Each employee holds a personal responsibility for the quality of the work that they perform.
Competency assessment and appraisal is used to ensure ongoing capability and identify individual personal development.
Managers and supervisors provide effective leadership and create a culture and working environment that allows operational performance and change management to be achieved by employees who are empowered to make suggestions and take decisions.
Key performance and quality indicators are used to enhance operational performance and remove variation from laboratory processes. Internal quality control and assurance known as OPMS (Operating Performance Managing System) is used as part of the overall assurance mechanism along with clinical and internal audit to monitor adequacy of operating procedures and effectiveness of the quality system.
Quality tools such as root cause analysis are used to ensure effective corrective actions are implemented and all lessons learned are disseminated in a timely manner. We require all our employees to comply with data legislation including the General Data Protection Regulations (2018) and the Data Protection Act (2018) in addition to Viapath policies. Data protection principles are reinforced throughout Viapath via Information Governance mandatory training .
We allow accreditation and regulatory bodies appropriate access to the knowledge systems maintained, to provide third party assurance to Viapath and our stakeholders.
Viapath is registered with the Care Quality Commission (CQC) as an independent healthcare provider at all locations on which it operates for the provision of Diagnostic and Screening Services and Blood and Transplant Services.